Thomas Mabey

Thomas Mabey

Auto-generated profile, based on publicly available information

Thomas Mabey

Department of Biochemistry, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok 10330, Thailand

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2015 in World Journal of Orthopedics
Verified
Journal Article
Open access
TMThomas Mabey
Thomas Mabey
SHSittisak Honsawek
Sittisak Honsawek
Osteoarthritis (OA) is a debilitating degenerative joint disease particularly affecting weightbearing joints within the body, principally the hips and knees. Current radiographic techniques are insufficient to show biochemical changes within joint tissue which can occur many years before symptoms become apparent. The need for better diagnostic and prognostic tools is heightened with the prevalence of OA set to increase in aging and obese populations. As inflammation is increasingly being considered an important part of OAs pathophysiology, cytokines are being assessed as possible candidates for biochemical markers. Cytokines, both pro- and anti-inflammatory, as well as angiogenic and chemotactic, have in recent years been studied for relevant characteristics. Biochemical markers show promise in determination of the severity of disease in addition to monitoring of the efficacy and safety of disease-modifying OA drugs, with the potential to act as diagnostic and prognostic tools. Currently, the diagnostic power of interleukin (IL)-6 and the relationship to disease burden of IL-1β, IL-15, tumor necrosis factor-α, and vascular endothelial growth factor make these the best candidates for assessment. Grouping appropriate cytokine markers together and assessing them collectively alongside other bone and cartilage degradation products will yield a more statistically powerful tool in research and clinical applications, and additionally aid in distinguishing between OA and a number of other diseases in which cytokines are known to have an involvement. Further large scale studies are needed to assess the validity and efficacy of current biomarkers, and to discover other potential biomarker candidates.

27 April 2016 in Biomarkers
Verified
Journal Article
Closed access
PDF file
TMThomas Mabey
Thomas Mabey
SHSittisak Honsawek
Sittisak Honsawek
ATAree Tanavalee
Aree Tanavalee
PYPongsak Yuktanandana
Pongsak Yuktanandana
VWVajara Wilairatana
Vajara Wilairatana
YPYong Poovorawan
Yong Poovorawan
Objective: The objective of this study is to compare inflammatory cytokine levels in primary knee osteoarthritis (OA) patients and healthy controls. Methods: A total of 32 knee OA patients and 14 healthy controls were enrolled. A multiplex immunoassay was utilized for 10 cytokines in plasma and synovial fluid. Results: Plasma IL-2, IL-4, and IL-6 concentrations were significantly greater in knee OA patients than controls. Moreover, both plasma IL-4 and IL-6 were positively correlated with the radiographic severity of knee OA. Conclusions: Plasma IL-4 and IL-6 may serve as biomarkers reflecting the severity of OA.

1 January 2015 in International Journal of Endocrinology
Verified
Journal Article
Open access
PDF file
TMThomas Mabey
Thomas Mabey
SHSittisak Honsawek
Sittisak Honsawek
Osteoarthritis is a debilitating and degenerative disease which affects millions of people worldwide. The causes and mechanisms of osteoarthritis remain to be fully understood. Vitamin D has been hypothesised to play essential roles in a number of diseases including osteoarthritis. Many cell types within osteoarthritic joints appear to experience negative effects often at increased sensitivity to vitamin D. These findings contrast clinical research which has identified vitamin D deficiency to have a worryingly high prevalence among osteoarthritis patients. Randomised-controlled trial is considered to be the most rigorous way of determining the effects of vitamin D supplementation on the development of osteoarthritis. Studies into the effects of low vitamin D levels on pain and joint function have to date yielded controversial results. Due to the apparent conflicting effects of vitamin D in knee osteoarthritis, further research is required to fully elucidate its role in the development and progression of the disease as well as assess the efficacy and safety of vitamin D supplementation as a therapeutic strategy.

26 June 2014 in International Orthopaedics
Verified
Journal Article
Closed access
PDF file
TMThomas Mabey
Thomas Mabey
SHSittisak Honsawek
Sittisak Honsawek
NSNatthaphon Saetan
Natthaphon Saetan
YPYong Poovorawan
Yong Poovorawan
ATAree Tanavalee
Aree Tanavalee
PYPongsak Yuktanandana
Pongsak Yuktanandana

1 May 2014 in Clinical Biochemistry
Verified
Journal Article
Closed access
TMThomas Mabey
Thomas Mabey
SHSittisak Honsawek
Sittisak Honsawek
ATAree Tanavalee
Aree Tanavalee
VWVajara Wilairatana
Vajara Wilairatana
PYPongsak Yuktanandana
Pongsak Yuktanandana
DZDong Zhan
Dong Zhan

2 January 2019 in Critical Reviews in Biotechnology
Verified
Journal Article
Closed access
TMThomas Mabey
Thomas Mabey
DCDomenico Andrea Cristaldi
Domenico Andrea Cristaldi
POPetra Oyston
Petra Oyston
KLKarl P. Lymer
Karl P. Lymer
ESEugen Stulz
Eugen Stulz
XZXunli Zhang
Xunli Zhang
Silver nanoparticles (AgNPs) have potential uses in many applications, but current chemical production methods are challenged by scalability, limited particle stability, and the use of hazardous chemicals. The biological processes present in bacteria to mitigate metallic contaminants in their environment present a potential solution to these challenges. Before commercial exploitation of this technology can be achieved, the quality of bacteriogenic AgNPs needs to be improved for certain applications. While the colloidal and morphological stabilities of biogenic AgNPs are widely regarded as superior to chemogenic particles, little control over the synthesis of particle morphologies has been achieved in biological systems. This article reviews a range of biosynthetic reaction conditions and how they affect AgNP formation in bacteria to understand which are most influential. While there remains uncertainty, some general trends are emerging: higher Ag+ concentrations result in higher AgNP production, up to a point at which the toxic effects begin to dominate; the optimal temperature appears to be heavily species-dependent and linked to the optimal growth temperature of the organism. However, hotter conditions generally favor higher production rates, while colder environments typically give greater shape diversity. Little attention has been paid to other potentially important growth conditions including halide concentrations, oxygen exposure, and irradiation with light. To fully exploit biosynthetic production routes as alternatives to chemical methods, hurdles remain with controlling particle morphologies and require further work to elucidate and harness them. By better understanding the factors influencing AgNP production, a foundation can be laid from which shape-controlled production can be achieved.